Ehrenstein, V, Huang, K, Kahlert, J, Bahmanyar, S, Karlsson, P, Löfling, L, Nunes, A P, Enger, C, Bezemer, I D, Kuiper, J G, Hoti, F, Juuti, R, Korhonen, P, Mo, J, Schachterle, S E, Wilner, K D, Rørth, M & Sørensen, H T 2021, ' Outcomes in patients with lung cancer treated with crizotinib and erlotinib in routine clinical practice : A post-authorization safety cohort study conducted in Europe and in the United States ', Pharmacoepidemiology and Drug Safety, vol. 30, no. 6, pp. 758-769 . https://doi.org/10.1002/pds.5193